logo

Ptc Therapeutics Inc. (PTCT)



Trade PTCT now with
  Date
  Headline
6/9/2021 8:13:50 AM PTC Therapeutics Elects Mary Smith To Board
5/26/2021 8:11:13 AM PTC Therapeutics: FDA And EC Grant Orphan Drug Designation For PTC923 For Patients With Hyperphenylalaninemia
5/17/2021 9:38:09 AM PTC Therapeuti : New Data Shows Devastating Impact Of AADC Deficiency On Caregivers
3/30/2021 1:02:11 AM PTC Therapeutics: European Commission Grants Marketing Authorization To Evrysdi For Spinal Muscular Atrophy
3/9/2021 8:11:17 AM SMA Foundation And PTC Expand Partnership To Advance Drug Discovery And Development Research In Regenerative Medicine
2/26/2021 6:57:44 AM CHMP Adopts Positive Opinion For Evrysdi For Spinal Muscular Atrophy In Adults And Children Aged Two Months And Older
2/17/2021 8:28:34 AM PTC Therapeutics Initiates Second Stage Of FITE19 Phase 2/3 Clinical Trial Evaluating PTC299 For COVID-19
12/4/2020 8:04:25 AM PTC Announces Translarna Approval In Russia For Treatment Of Duchenne Muscular Dystrophy
11/30/2020 8:21:05 AM PTC Therapeutics Initiates Global Phase 3 Clinical Trial To Evaluate Vatiquinone In Friedreich Ataxia
11/17/2020 8:07:37 AM PTC Therapeutics Says PTC518 Enters Into Phase 1 Trial For Huntington's Disease Program
10/26/2020 8:19:06 AM PTC Therapeutics Begins Registration-Directed Clinical Trial To Evaluate Vatiquinone In Mitochondrial Epilepsy
8/17/2020 8:11:05 AM PTC : EU Accepts Marketing Authorization Application For Evrysdi For Treatment Of Spinal Muscular Atrophy